Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2012

View Archived Issues

Intravaginal ring technology gains attention for HIV prevention / News in Context

Almirall describes novel SYK inhibitors at ongoing ACS meeting

In-fiber method allows scalable production of uniform structured spheres for drug delivery

FDA grants orphan drug status to mondoBIOTECH product

Dainippon Sumitomo Pharma establishes new oncology institute

New sildenafil formulation launched in Korea to treat erectile dysfunction

Abbott to launch next-generation drug-eluting stent

Pivotal BEMA-buprenorphine/naloxone trial advances

Treatment begins in trial of JVS-100 for late-stage heart failure

Gilead Sciences presents new candidate therapeutics for hepatitis

Novartis divulges new glutamate receptor antagonists

New cathepsin A inhibitors patented by Sanofi

Collaboration yields novel prostanoid EP1 receptor antagonists

Proximagen discloses novel PAR2 receptor antagonists

Novel prostanoid FP receptor agonists designed in Japan

Investigational BCR-ABL inhibitor enters new phase I/II trial in Japan

Novel IL-17A/IL-17F inhibitors identified at 4SC

New mutation linked to persistent hyperplasia of the primary vitreous

FDA requests additional information for MoxDuo NDA

U.S. university and Novartis launch exclusive licensing agreement

Alligator Bioscience enters agreement with biotech company

Inspiration Biopharmaceuticals and Ipsen restructure strategic alliance

Travoprost punctum plug for glaucoma advances to phase II

New lotion against head lice launched in U.S.

FDA approves new dosages of sublingual film for opioid dependence

Kineta clear to move first K(V)1.3 channel-specific antagonist into clinic

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...